Caxton Associates (New York)’s Voyager Therapeutics VYGR Stock Holding History

Caxton Associates (New York)’s Portfolio VYGR Stock Details VYGR Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell
2023 Q2	$252K	Sell
2023 Q1	$282K	Sell
2022 Q4	$651K	Sell
2022 Q3	$809K	Hold
2022 Q2	$807K	Hold
2022 Q1	$1.04M	Buy